MSME (Udyam registered) Ministry of MSME
- Category
- Small (2024-25)
- Udyam number
- UDYAM-DL-04-0008153
Medglobe Therapeutics Limited - pharma in Delhi, India. FY 2026 financials & compliance.
Revenue · FY 2023
₹21.04 Cr
▲ 73% YoY
Net profit · FY 2023
₹1.05 Cr
Net margin 5%
EBITDA · FY 2023
₹1.97 Cr
EBITDA margin 9.4%
Authorised capital
₹5 Cr
Registered with MCA
Paid-up capital
₹2.85 Cr
Issued & subscribed
Open charges
₹4 Cr
Satisfied ₹6.6 Cr
Company age
20 yrs
Est. 2006
Employees · EPFO
57
Provident fund records
About Medglobe Therapeutics Limited
Data last updated:
Medglobe Therapeutics Limited is a public limited company based in Delhi, India. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 24 April 2006 and has been in existence for over 20 years.
The company is registered with the Registrar of Companies (ROC), Delhi, under CIN U24239DL2006PLC368703. Its GSTIN is 05AAACO8308C1ZV (Uttarakhand). The company holds 2 GST registrations, of which 1 is active.
The company has an authorised share capital of ₹5 Cr and a paid-up capital of ₹2.85 Cr. It was formerly known as Opus Life Sciences Limited. It is led by directors including Varun Singh and Anuj Kumar Garawal.
Its last annual general meeting (AGM) was held on 29 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at 5/9 A Roop Nagar, Delhi, India – 110007.
As per the financials filed for FY 2023, the company reported a revenue of ₹21.04 Cr, a growth of 73% compared to the previous year. For the same year it recorded a net profit of ₹1.05 Cr (net margin 5%) and EBITDA of ₹1.97 Cr (EBITDA margin 9.4%). Revenue has grown at a compounded annual rate (CAGR) of 99% over three years and 19% over five years.
The company has about 57 employees on its provident fund (EPFO) records.
The company is associated with 1 brand: Medglobe. As per MCA filings, the company has open charges of ₹4 Cr and satisfied charges of ₹6.6 Cr on record. Court records list 8 cases involving the company, including 2 filed by the company and 6 filed against it; 3 cases are pending.
Medglobe Therapeutics Limited is registered as a small enterprise under the Udyam registration framework (Reg. No. UDYAM-DL-04-0008153). The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website medglobe.co.in.
Company details
CIN U24239DL2006PLC368703
Registration Number 368703
Incorporation Date 24 April 2006
ROC Delhi
Listing Status Unlisted
Company Status Active
Date of Last AGM 29 September 2025
Date of Balance Sheet 31 March 2025
Compliance Status Active Compliant
MSME Classification Small
Udyam Registration UDYAM-DL-04-0008153
CIN history
Medglobe Therapeutics has 2 previous CINs, indicating changes in the company's corporate structure or registration details. The current CIN is U24239DL2006PLC368703, which is the unique identifier assigned by the Registrar of Companies.
| CIN | Status |
|---|---|
| U24239DL2006PLC368703 | Current |
| U24239TG2006PLC050002 | Previous |
| U24239AP2006PLC050002 | Previous |
Recognitions & Rankings of Medglobe Therapeutics
Contact details
Medglobe Therapeutics Limited's registered office is in Delhi, Delhi. Its website is medglobe.co.in. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Website
- Registered Address5/9 A Roop Nagar, Delhi, India – 110007
- IndustryPharma, Drug Formulation & Development
To see the full contact details of Medglobe Therapeutics Limited, buy the company report.
Comprehensive company report
Medglobe Therapeutics Limited - one report that includes everything
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included
Brands
Medglobe Therapeutics operates one associated brand: Medglobe. Each brand links to its own profile.
| Brand | Description | Website |
|---|---|---|
| Manufacturing and marketing of pharmaceutical formulations in domestic markets. | medglobe.co.in |
Financials of Medglobe Therapeutics Limited
FY 2025 filings availableMedglobe Therapeutics Limited reported revenue of ₹21.04 Cr (up 73% YoY) for FY 2023.
Revenue · FY 2023
₹21.04 Cr ▲ 73%
Net profit · FY 2023
₹1.05 Cr margin 5%
EBITDA · FY 2023
₹1.97 Cr margin 9.4%
Compounded Annual Growth Rate (CAGR)
Revenue CAGR growth
1 year
▲ 73%
3 years · compounded
▲ 99%
5 years · compounded
▲ 19%
EBITDA CAGR growth
1 year
▲ 43%
3 years · compounded
▲ 57%
5 years · compounded
▲ 63%
Revenue has grown at a compounded annual rate (CAGR) of 19% over five years, including 73% growth in the latest year. EBITDA rose 43% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 | FY 2018-19 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | ₹21.04 Cr | ||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹1.97 Cr | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹1.05 Cr | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 | FY 2018-19 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 9.4% | ||||
| Net Profit Margin | 5% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Medglobe Therapeutics Limited, buy the company report.
Board of directors of Medglobe Therapeutics Limited
Medglobe Therapeutics has 3 current directors and 23 former directors. Current directors are listed first, with their designation and appointment date.
Current Directors
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Varun Singh Also directs: Khokar Associates Limited, Hercules Nutra Private Limited | Director | 05 Mar 2019 | 7 Years 7 Months | Current |
| Anuj Kumar Garawal Also directs: Yg Foods Private Limited | Director | 03 Jan 2019 | 7 Years 9 Months | Current |
| Amit Singh | Director | 03 Jan 2019 | 7 Years 9 Months | Current |
Auditor
Medglobe Therapeutics Limited is audited by RAJNISH ARVIND & ASSOCIATES for the financial year 2023.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| RAJNISH ARVIND & ASSOCIATES | FY 2023 | 009313C |
Shareholding
The shareholding of Medglobe Therapeutics Limited is on record for 5 financial years, the latest being FY 2023, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
|---|---|---|---|---|---|
| Promoters | |||||
| Domestic institutional investors (DII) | |||||
| Foreign institutional investors (FII) | |||||
| Public | |||||
| Others |
To see the full shareholding pattern of Medglobe Therapeutics Limited, buy the company report.
Charges & borrowings
Open charges
₹4 Cr
Satisfied charges
₹6.6 Cr
Breakdown by lending institutions
Latest charge details
| Date | Charge ID | Lender | Amount | Status | Modified or satisfied on |
|---|---|---|---|---|---|
| 25 Nov 2025 | 101215257 | Others | ₹3 Cr | Open | |
| 25 Nov 2025 | 101215264 | Others | ₹1 Cr | Open | |
| 04 Jun 2024 | 100952782 | Others | ₹4.1 Cr | Satisfied | |
| 01 Sep 2006 | 10085225 | Punjab National Bank | ₹2.5 Cr | Satisfied |
To see the full charge records of Medglobe Therapeutics Limited, buy the company report.
Total charge records: 4 View all charges
Legal cases
Medglobe Therapeutics Limited has 8 court cases on record: 2 filed by Medglobe Therapeutics, 6 filed against it. 3 cases are pending and 5 are disposed.
Total cases
8
Filed by the company
2
Filed against the company
6
Pending
3
Disposed
5
Cases by court
| Court | Cases | Against the company | Pending |
|---|---|---|---|
| District courts | 5 | 4 | 3 |
| High courts | 3 | 2 | 0 |
Cases on record (5 of 8)
| Court | Type of case | Party | Status |
|---|---|---|---|
| District court, TUMAKURU, Karnataka | Criminal complaint | Filed against the company by State at the Instance of Assistant Drugs Controller-2 | Pending |
| District court, Jhansi, Uttar Pradesh | Court case (Special Trial) | Filed against the company by State Government | Pending |
| District court, Visakapatnam, Andhra Pradesh | Court case (CRLA.MU) | Filed by the company against State Rep by Its Addl.Pp | Pending |
| High Court, ANDHRAPRADESH | Court case (CRLP) | Filed against the company by an individual | Disposed |
| District court, Mumbai City Civil Court, Maharashtra | Civil suit | Filed against the company by an individual | Disposed |
To see the full case history of Medglobe Therapeutics Limited, buy the company report.
Case records are compiled from court listings and may lag the court's own records. A case filed against a company is not a finding against it.
MSME payment delays
Medglobe Therapeutics Limited has 4 MSME Form 1 returns on record between 2019 and 2020, listing 33 overdue payments to 8 micro and small suppliers. Companies must report dues to micro and small suppliers that stay unpaid for more than 45 days in a half-yearly MSME Form 1 return.
Suppliers with reported dues (5 of 8)
| Supplier | Amount due | Due since | Reported on |
|---|---|---|---|
| an individual supplier | |||
| an individual supplier | |||
| an individual supplier | |||
| Roorkee Research & Analytical Labs Private Limited | |||
| an individual supplier |
To see the full MSME payment records of Medglobe Therapeutics Limited, buy the company report.
Individuals and sole proprietors among the suppliers are not named.
Employees & EPFO
Medglobe Therapeutics Limited has a workforce of 57 employees on its EPFO records as of Apr 07, 2024, across 1 active EPFO establishment.
Employee count
57
Active EPFO establishments
1
Employee growth
16.33%
GST
Medglobe Therapeutics has 2 GST registrations: 1 active and 1 cancelled or inactive.
Total GSTINs
2
Active
1
Cancelled / inactive
1
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 05AAACO8308C1ZV | Uttarakhand | Active | 01 Jul 2017 |
To see the full GST registrations and return filing status of Medglobe Therapeutics Limited, buy the company report.
Recent activity
Medglobe Therapeutics Limited has 49 board changes on record since 2006: 26 appointments and 23 cessations. The latest: Bhaskara Reddy Kunduru ceased to be Additional Director on 11 May 2019.
Charges
A charge registered on 04 Jun 2024 via Charge ID 100952782 with Others was fully satisfied on 14 Jan 2026.
Charges
A charge with Others amounted to Rs. 3.00 Cr with Charge ID 101215257 was registered on 25 Nov 2025.
Charges
A charge with Others amounted to Rs. 1.00 Cr with Charge ID 101215264 was registered on 25 Nov 2025.
AGM
Medglobe Therapeutics Limited last Annual general meeting of members was held on 29 Sep 2025 as per latest MCA records.
Filing
Medglobe Therapeutics Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Delhi.
Charges
A charge with Others of Rs. 4.10 Cr registered on 04 Jun 2024 with Charge ID 100952782 was modified on 24 Aug 2024.
Charges
A charge with Others amounted to Rs. 4.10 Cr with Charge ID 100952782 was registered on 04 Jun 2024.
Charges
A charge registered on 01 Sep 2006 via Charge ID 10085225 with Punjab National Bank was fully satisfied on 09 Feb 2021.
Ceased
Bhaskara Reddy Kunduru ceased to be Additional Director.
Ceased
Harish Raju Penumatsa ceased to be Director.
Ceased
Venkata Satya Mudunuri Suryanarayana Raju ceased to be Additional Director.
Ceased
Anuj Kumar ceased to be Director.
48 earlier events are in the company report.
Frequently asked questions
Medglobe Therapeutics is an active public limited company based in Delhi, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 24 April 2006 (20+ years old) and is registered under CIN U24239DL2006PLC368703.
Medglobe Therapeutics has 3 current directors:
- Varun Singh - Director
- Anuj Kumar Garawal - Director
- Amit Singh - Director
The latest financial statements of Medglobe Therapeutics on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 29 September 2025. Year-wise statements from 2015 are in the company report.
The GSTIN of Medglobe Therapeutics is 05AAACO8308C1ZV, registered in Uttarakhand. The company has 2 GST registrations in all, of which 1 is active and 1 is cancelled or inactive.
The CIN (Corporate Identification Number) of Medglobe Therapeutics is U24239DL2006PLC368703. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Medglobe Therapeutics has 8 court cases on record: 2 filed by the company and 6 filed against it. 3 are pending. Most are in the district courts.
Medglobe Therapeutics was incorporated on 24 April 2006, making it 20+ years old. It is registered with the Registrar of Companies, Delhi.
Bhaskara Reddy Kunduru ceased to be Additional Director on 11 May 2019. Harish Raju Penumatsa ceased to be Director on 11 May 2019. Venkata Satya Mudunuri Suryanarayana Raju ceased to be Additional Director on 11 May 2019. Medglobe Therapeutics has 49 board changes on record in total.
Yes, Medglobe Therapeutics is registered as a small enterprise under Udyam registration (number: UDYAM-DL-04-0008153).
Medglobe Therapeutics has 4 MSME Form 1 returns on record between 2019 and 2020, listing 33 overdue payments to 8 micro and small suppliers. The latest return was filed on 22 Sep 2020.
Medglobe Therapeutics can be reached through the website medglobe.co.in. Its registered office is in Delhi, India.